BriaCell Total Assets from 2010 to 2024

BCTXW Stock

USD 0.51 0.01 2.00%

BriaCell Therapeutics Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2006-07-31

Previous Quarter

6.2 M

Current Value

5.9 M

Quarterly Volatility

14.8 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check BriaCell Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BriaCell Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.4 K, Interest Expense of 0.0 or Other Operating Expenses of 35 M, as well as many indicators such as Price To Sales Ratio of 0.0, Days Sales Outstanding of 0.0 or Invested Capital of 622.1 K. BriaCell financial statements analysis is a perfect complement when working with BriaCell Therapeutics Valuation or Volatility modules.

Check out the analysis of BriaCell Therapeutics Correlation against competitors.

Latest BriaCell Therapeutics' Total Assets Growth Pattern

Below is the plot of the Total Assets of BriaCell Therapeutics Corp over the last few years. Total assets refers to the total amount of BriaCell Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in BriaCell Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. BriaCell Therapeutics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BriaCell Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 5.87 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

BriaCell Total Assets Regression Statistics

	Arithmetic Mean	11,556,064
	Geometric Mean	3,359,166
	Coefficient Of Variation	151.13
	Mean Deviation	12,415,492
	Median	2,588,915
	Standard Deviation	17,465,152
	Sample Variance	305T
	Range	57.9M
	R-Value	0.42
	Mean Square Error	269.8T
	R-Squared	0.18
	Significance	0.12
	Slope	1,650,565
	Total Sum of Squares	4270.4T

BriaCell Total Assets History

	2024	10.3 M
	2023	5.9 M
	2022	27.2 M
	2021	42.6 M
	2020	58 M
	2019	478.3 K
	2018	415.4 K

Other Fundumenentals of BriaCell Therapeutics

Intangibles To Total Assets

BriaCell Therapeutics Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Net Receivables	Intangible Assets	Current Deferred Revenue	Net Invested Capital	Long Term Investments	Net Working Capital	Long Term Debt	Short Long Term Debt	Capital Stock	Short Term Debt	Common Stock
Total Assets		0.79	-0.98	-0.33	-0.01	0.52	0.98	0.02	0.42	-0.44	0.79	-0.08	0.97	-0.56	-0.51	0.69	-0.51	0.69
Total Stockholder Equity	0.79		-0.8	0.18	-0.2	-0.1	0.77	-0.26	0.17	-0.13	0.98	-0.2	0.78	-0.2	-0.17	0.24	-0.17	0.24
Net Debt	-0.98	-0.8		0.24	0.11	-0.49	-1.0	0.09	-0.43	0.42	-0.83	0.17	-0.99	0.54	0.49	-0.63	0.49	-0.63
Retained Earnings	-0.33	0.18	0.24		-0.79	-0.7	-0.3	-0.86	-0.52	0.65	0.13	-0.71	-0.2	0.78	0.74	-0.88	0.74	-0.88
Accounts Payable	-0.01	-0.2	0.11	-0.79		0.13	-0.07	0.97	0.27	-0.42	-0.17	0.99	-0.19	-0.52	-0.5	0.58	-0.5	0.58
Total Liab	0.52	-0.1	-0.49	-0.7	0.13		0.54	0.27	0.42	-0.48	-0.07	0.03	0.51	-0.58	-0.54	0.74	-0.54	0.74
Total Current Assets	0.98	0.77	-1.0	-0.3	-0.07	0.54		-0.04	0.45	-0.45	0.8	-0.14	0.99	-0.57	-0.52	0.68	-0.52	0.68
Net Receivables	0.02	-0.26	0.09	-0.86	0.97	0.27	-0.04		0.3	-0.45	-0.23	0.93	-0.15	-0.56	-0.53	0.65	-0.53	0.65
Intangible Assets	0.42	0.17	-0.43	-0.52	0.27	0.42	0.45	0.3		-0.98	0.26	0.23	0.38	-0.79	-0.8	0.57	-0.8	0.57
Current Deferred Revenue	-0.44	-0.13	0.42	0.65	-0.42	-0.48	-0.45	-0.45	-0.98		-0.21	-0.37	-0.37	0.87	0.88	-0.67	0.88	-0.67
Net Invested Capital	0.79	0.98	-0.83	0.13	-0.17	-0.07	0.8	-0.23	0.26	-0.21		-0.18	0.81	-0.26	-0.23	0.29	-0.23	0.29
Long Term Investments	-0.08	-0.2	0.17	-0.71	0.99	0.03	-0.14	0.93	0.23	-0.37	-0.18		-0.25	-0.46	-0.45	0.5	-0.45	0.5
Net Working Capital	0.97	0.78	-0.99	-0.2	-0.19	0.51	0.99	-0.15	0.38	-0.37	0.81	-0.25		-0.47	-0.42	0.59	-0.42	0.59
Long Term Debt	-0.56	-0.2	0.54	0.78	-0.52	-0.58	-0.57	-0.56	-0.79	0.87	-0.26	-0.46	-0.47		1.0	-0.83	1.0	-0.83
Short Long Term Debt	-0.51	-0.17	0.49	0.74	-0.5	-0.54	-0.52	-0.53	-0.8	0.88	-0.23	-0.45	-0.42	1.0		-0.78	1.0	-0.78
Capital Stock	0.69	0.24	-0.63	-0.88	0.58	0.74	0.68	0.65	0.57	-0.67	0.29	0.5	0.59	-0.83	-0.78		-0.78	1.0
Short Term Debt	-0.51	-0.17	0.49	0.74	-0.5	-0.54	-0.52	-0.53	-0.8	0.88	-0.23	-0.45	-0.42	1.0	1.0	-0.78		-0.78
Common Stock	0.69	0.24	-0.63	-0.88	0.58	0.74	0.68	0.65	0.57	-0.67	0.29	0.5	0.59	-0.83	-0.78	1.0	-0.78

Click cells to compare fundamentals

About BriaCell Therapeutics Financial Statements

BriaCell Therapeutics investors use historical fundamental indicators, such as BriaCell Therapeutics' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BriaCell Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	5.9 M	10.3 M
Intangibles To Total Assets	0.03	0.03

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for BriaCell Stock Analysis

When running BriaCell Therapeutics' price analysis, check to measure BriaCell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BriaCell Therapeutics is operating at the current time. Most of BriaCell Therapeutics' value examination focuses on studying past and present price action to predict the probability of BriaCell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BriaCell Therapeutics' price. Additionally, you may evaluate how the addition of BriaCell Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC